AD
Tempus logo

Tempus

Subscription🇺🇸

AI-Powered Precision Medicine & Genomic Testing

80

Overall score

26

Heat score

Pricing

No pricing plans published yet.

Technical Specs

Inputs

Genomic Data, Clinical Records, Pathology Slides, Radiology Images

Outputs

Actionable Insights, Treatment Recommendations, Personalized Medicine Strategies

AI Type

Other

Model Architecture

Custom/Proprietary

Daily Prompts

N/A

Context Length

N/A

Output Quality

Accuracy

80%

Content

80%

Reasoning

80%

Company Profile

Company

Tempus

Founded

2015

HQ

Chicago, Illinois

Employees

N/A

Total Raised / Total Funding

$1.3B

Revenue

N/A

Valuation

N/A

ARR

N/A

CEO

Eric Lefkofsky

Overview

Estimated Paid Users

N/A

Current estimate

Total Earnings Till Date

N/A

No monthly delta yet

Market Share

N/A

Current share

Average Session

N/A

Per active user

Hallucination Rate

80%

Model quality signal

Growth Rate

N/A

Monthly active users

Burn Rate

N/A

Total expenses / years active

Paid User Gain

N/A

Monthly paid user trend

No demo video available yet.

Platforms

AD

Performance Metrics

Accuracy

80%

Context

80%

Reasoning

80%

Safety

80%

Benchmarks

No benchmark scores available.

Tempus Models

No model/version data available.

Funding Rounds & Investors

Total Funding

$1.3B

Rounds

2

Series A

$1.26B

Oct 2022

Source: Tracxn

Seed

$4M

Nov 2021

Source: Crunchbase

Founders/Team

EL

Eric Lefkofsky

Founder and CEO

Direct competitors

No direct competitors available.

Change Log / Major Updates

No changelog entries available.

Compliance, Integrations & Support

Industry: Not specified

Compliances: Not specified

Integrations: Not specified

Support:Email

Target audience: Healthcare Providers, Researchers, Oncologists, Geneticists, Clinicians, Patients, Data Scientists, Pharmaceutical Companies

Supported languages: English

Tempus Acquisitions

No acquisition records available.

AD

Reviews & Rating

0 reviews

No reviews yet

Be the first to share how Tempus performs for your workflow.

0.0

Accuracy

0.0

Ease of Use

0.0

Output Quality

0.0

Security

0.0

More About Tempus

Founded in 2015 by Eric Lefkofsky, Tempus AI is a leader in artificial intelligence-driven healthcare solutions. The company's mission is to build the world's largest library of clinical and molecular data, making it accessible and useful for healthcare providers and researchers.

After Lefkofsky's wife was diagnosed with breast cancer, he founded Tempus to develop tools that could help personalize treatment plans. The platform integrates genomic sequencing with deep clinical records, pathology slides, and radiology images to provide actionable insights for personalized medicine.

Tempus has raised over $1.3 billion in funding from investors including Revolution, Google, and New Enterprise Associates. The company's technology is being used by healthcare providers and pharmaceutical companies to accelerate discovery and improve patient care.

  1. Key Capabilities: Genomic analysis, clinical data integration, predictive modeling, personalized treatment recommendations
  2. What Makes it Different: Tempus combines large-scale genomic data with clinical records to provide a comprehensive view of patient health, enabling more precise treatment decisions.
  3. Traction: The platform has been used in thousands of patient cases and has partnered with major healthcare institutions and pharmaceutical companies.

Tempus FAQ's

No FAQs available.